PG
PROCTER & GAMBLE Co
$149.61
+0.86%
$348.4B
No data for this timeframe.
Vol
Market Cap$348.4B
Cap SizeMega Cap
Analyst ConsensusBuy (61%)
Inst. Holders50 funds
Inst. Value$141.4B
Inst. Activity34 buys / 16 sells
Insider Activity0B / 8S
Insider Net $-$40.9M
Reddit Sentiment33° Cool
SEC Reports5
Congressional8 trades
Exchange NYSE·Sector Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics·Inc. OH·CIK 0000080424·Prev Close $148.34
Recent Activity
Jul 27, 2026
earnings_calendar
PG Q4 2026 Earnings After Market Close — 2026-07-27
EPS est: $1.58 | Rev est: $22.2B
Jun 12, 2026
SEC
Bernstein initiates PG at Market Perform — PT $156 (+5.2%)
ANALYST-UPGRADE — Impact 2/10
Jun 9, 2026
Insider
ARNOLD CRAIG was granted 202 shares
Director
Jun 9, 2026
Insider
JIMENEZ JOSEPH was granted 320 shares
Director
Jun 9, 2026
Insider
Kempczinski Christopher J was granted 258 shares
Director
Jun 4, 2026
SEC
The Sixth Circuit affirmed the district court's denial of a preliminary injunction sought by Scotts Miracle-Gro against
COURT-RULING — Impact 5/10
May 31, 2026
SEC
JP Morgan upgrades PG to Overweight — PT $165 (+15.0%)
ANALYST-UPGRADE — Impact 4/10
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — DOUBLED
41,360,143 shares ($6.0B)
Price Targets
$163.43
+9.2% upside
Buy
Current $149.61
Low $145.00
Median $164.00
High $186.00
23 analysts
$145.00
$186.00
Analyst Ratings
8Strong Buy
14Buy
13Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 11, 2026 | Bernstein | INITIATE | Market Perform |
| Apr 27, 2026 | UBS | MAINTAIN | Buy → Buy |
| Apr 27, 2026 | TD Cowen | MAINTAIN | Hold → Hold |
| Apr 27, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| Apr 27, 2026 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.42 | $1.37 — $1.46 | -4% YoY | 19 |
| Next Q | $1.97 | $1.93 — $2.07 | -1% YoY | 14 |
| Current FY | $6.90 | $6.83 — $7.02 | 1% YoY | 24 |
| Next FY | $7.09 | $6.96 — $7.34 | 3% YoY | 24 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $27.0B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $21.8B | — |
| STATE STREET CORP | $14.6B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.1B | — |
| MORGAN STANLEY | $7.1B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | ARNOLD CRAIG | A | $0.00 |
| Jun 9, 2026 | JIMENEZ JOSEPH | A | $0.00 |
| Jun 9, 2026 | Kempczinski Christopher | A | $0.00 |
| Jun 9, 2026 | McCarthy Christine | A | $0.00 |
| Jun 9, 2026 | McEvoy Ashley | A | $0.00 |
Reddit Sentiment
33°▼
Cool
Bearish
Neutral
Bullish
Congressional Trades
5 members: 5 buys, 3 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| David Taylor | R | BUY | $1,001 - $15,000 |
| David Taylor | R | BUY | $1,001 - $15,000 |
| John Boozman | R | SELL | $1,001 - $15,000 |
50 institutional holders with $141.4B total value (979,011,673 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 34 institutions added/increased vs 16 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 187,029,747 | $27.0B | 19.1% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 151,049,902 | $21.8B | 15.4% | — |
| 3 | STATE STREET CORP | 101,250,847 | $14.6B | 10.3% | — |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 62,847,265 | $9.1B | 6.4% | — |
| 5 | MORGAN STANLEY | 49,216,260 | $7.1B | 5.0% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 41,360,143 | $6.0B | 4.2% | DOUBLED +120.2% |
| 7 | FMR LLC | 30,709,456 | $4.4B | 3.1% | — |
| 8 | FRANKLIN RESOURCES INC | 27,796,251 | $4.0B | 2.8% | — |
| 9 | BANK OF AMERICA CORP /DE/ | 26,341,321 | $3.8B | 2.7% | — |
| 10 | GOLDMAN SACHS GROUP INC | 17,322,319 | $2.5B | 1.8% | — |
| 11 | Legal & General Group Plc | 16,204,029 | $2.3B | 1.7% | — |
| 12 | AMERIPRISE FINANCIAL INC | 14,693,469 | $2.1B | 1.5% | — |
| 13 | WELLS FARGO & COMPANY/MN | 14,373,215 | $2.1B | 1.5% | — |
| 14 | ROYAL BANK OF CANADA | 14,120,442 | $2.0B | 1.4% | — |
| 15 | VANGUARD FIDUCIARY TRUST CO | 13,085,089 | $1.9B | 1.3% | — |
| 16 | Invesco Ltd. | 12,801,385 | $1.8B | 1.3% | — |
| 17 | Nuveen, LLC | 12,576,518 | $1.8B | 1.3% | — |
| 18 | DIMENSIONAL FUND ADVISORS LP | 11,797,916 | $1.7B | 1.2% | — |
| 19 | Mitsubishi UFJ Asset Management Co., Ltd. | 9,997,367 | $1.4B | 1.0% | — |
| 20 | Amundi | 9,160,507 | $1.3B | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 18,779,055 | 41,360,143 | +120.2% | $6.0B | 2026-Q1 |
| Capital World Investors | ADD | 4,401,827 | 7,434,848 | +68.9% | $1.1B | 2026-Q1 |
| FIFTH THIRD BANCORP | ADD | 2,090,971 | 2,783,395 | +33.1% | $402.0M | 2026-Q1 |
| Point72 Asset Management, L.P. | DOUBLED | 590,414 | 2,100,311 | +255.7% | $303.4M | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | ADD | 1,528,142 | 2,087,683 | +36.6% | $301.3M | 2026-Q1 |
| Assenagon Asset Management S.A. | TRIM | 5,460,939 | 2,043,519 | -62.6% | $295.2M | 2026-Q1 |
| Capital International Investors | TRIM | 4,670,565 | 2,037,272 | -56.4% | $294.3M | 2026-Q1 |
| MACKENZIE FINANCIAL CORP | ADD | 1,433,647 | 2,025,925 | +41.3% | $292.6M | 2026-Q1 |
| NORDEA INVESTMENT MANAGEMENT AB | TRIM | 2,430,758 | 1,807,965 | -25.6% | $257.4M | 2026-Q1 |
| M&T BANK CORP | DOUBLED | 39,411 | 1,215,075 | +2983.1% | $175.5M | 2026-Q1 |
| Rockefeller Capital Management L.P. | TRIM | 2,433,977 | 1,196,415 | -50.8% | $172.8M | 2026-Q1 |
| Mirae Asset Global Investments Co., Ltd. | DOUBLED | 432,330 | 1,195,421 | +176.5% | $172.7M | 2026-Q1 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | ADD | 736,378 | 1,184,928 | +60.9% | $171.2M | 2026-Q1 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | TRIM | 1,718,923 | 1,255,704 | -26.9% | $164.3M | 2026-Q1 |
| Allianz Asset Management GmbH | ADD | 614,628 | 1,119,526 | +82.1% | $161.7M | 2026-Q1 |
| BROWN BROTHERS HARRIMAN & CO | ADD | 771,420 | 966,537 | +25.3% | $139.6M | 2026-Q1 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | DOUBLED | 229,275 | 903,429 | +294.0% | $130.5M | 2026-Q1 |
| Grantham, Mayo, Van Otterloo & Co. LLC | ADD | 671,372 | 893,434 | +33.1% | $129.0M | 2026-Q1 |
| NATIXIS | ADD | 419,024 | 827,854 | +97.6% | $119.6M | 2026-Q1 |
| Retirement Systems of Alabama | TRIM | 1,003,924 | 747,130 | -25.6% | $107.9M | 2026-Q1 |
| &PARTNERS | ADD | 524,020 | 686,805 | +31.1% | $99.1M | 2026-Q1 |
| TD Waterhouse Canada Inc. | ADD | 407,517 | 574,800 | +41.0% | $82.7M | 2026-Q1 |
| Tredje AP-fonden | TRIM | 936,437 | 560,217 | -40.2% | $80.9M | 2026-Q1 |
| Daiwa Securities Group Inc. | TRIM | 1,287,416 | 489,857 | -62.0% | $70.8M | 2026-Q1 |
| Zurich Insurance Group Ltd/FI | DOUBLED | 29,470 | 482,151 | +1536.1% | $69.6M | 2026-Q1 |
12 unique insiders with 29 transactions. Net insider value: -$40.9M ($0.00 bought, $40.9M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | ARNOLD CRAIG | Director | AWARD | 202 | — | — |
| Jun 9, 2026 | JIMENEZ JOSEPH | Director | AWARD | 320 | — | — |
| Jun 9, 2026 | Kempczinski Christopher J | Director | AWARD | 258 | — | — |
| Jun 9, 2026 | McCarthy Christine M | Director | AWARD | 253 | — | — |
| Jun 9, 2026 | McEvoy Ashley | Director | AWARD | 202 | — | — |
| Jun 9, 2026 | Portman Robert Jones | Director | AWARD | 51 | — | — |
| Mar 10, 2026 | ARNOLD CRAIG | Director | AWARD | 161 | — | — |
| Mar 10, 2026 | JIMENEZ JOSEPH | Director | AWARD | 273 | — | — |
| Mar 10, 2026 | McCarthy Christine M | Director | AWARD | 209 | — | — |
| Mar 10, 2026 | McEvoy Ashley | Director | AWARD | 161 | — | — |
| Mar 10, 2026 | Portman Robert Jones | Director | AWARD | 193 | — | — |
| Mar 10, 2026 | Kempczinski Christopher J | Director | AWARD | 201 | — | — |
| Mar 10, 2026 | Portman Robert Jones | Director | AWARD | 49 | — | — |
| Feb 27, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | SELL | 5,249 | $165.29 | $867.6K |
| Feb 19, 2026 | Whaley Susan Street | Chief Legal Officer & Secy | SELL | 1,809 | $159.46 | $288.5K |
| Feb 17, 2026 | Whaley Susan Street | Chief Legal Officer & Secy | AWARD | 11.485 | — | — |
| Feb 17, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | AWARD | 57.003 | — | — |
| Feb 13, 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | SELL | 15,169 | $162.28 | $2.5M |
| Feb 13, 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | EXERCISE | 15,169 | $91.07 | $1.4M |
| Feb 12, 2026 | Moeller Jon R | Exec. Chairman of the Board | SELL | 162,232 | $162.45 | $26.4M |
| Feb 12, 2026 | Moeller Jon R | Exec. Chairman of the Board | EXERCISE | 162,232 | $113.23 | $18.4M |
| Feb 12, 2026 | Coombe Gary A | CEO - Grooming | SELL | 36,093 | $162.33 | $5.9M |
| Feb 12, 2026 | Coombe Gary A | CEO - Grooming | EXERCISE | 36,093 | $78.52 | $2.8M |
| Feb 11, 2026 | Moeller Jon R | Exec. Chairman of the Board | SELL | 11,036 | $160.00 | $1.8M |
| Feb 11, 2026 | Moeller Jon R | Exec. Chairman of the Board | EXERCISE | 11,036 | $113.23 | $1.2M |
| Feb 11, 2026 | Purushothaman Balaji | Chief Human Resources Officer | SELL | 12,827 | $160.31 | $2.1M |
| Feb 11, 2026 | Purushothaman Balaji | Chief Human Resources Officer | EXERCISE | 12,827 | $91.07 | $1.2M |
| Feb 4, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | SELL | 8,000 | $158.00 | $1.3M |
| Nov 17, 2025 | Coombe Gary A | CEO - Grooming | AWARD | 63.689 | — | — |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.0/10.
BULLISH
ANALYST-UPGRADE
4/10
JP Morgan upgrades PG to Overweight — PT $165 (+15.0%)
May 31, 2026
NEUTRAL
ANALYST-UPGRADE
2/10
Bernstein initiates PG at Market Perform — PT $156 (+5.2%)
Jun 12, 2026
BULLISH
COURT-RULING
5/10
The Sixth Circuit affirmed the district court's denial of a preliminary injunction sought by Scotts
Jun 4, 2026
NEUTRAL
8-K
5/10
Procter & Gamble reported Q3 FY2026 results showing 3% organic sales growth and 3% core EPS growth,
Apr 24, 2026
NEUTRAL
8-K
4/10
Procter & Gamble reported Q3 fiscal 2026 revenue of $21.2 billion (7% YoY growth, 3% organic) and di
Apr 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (61% buy). Based on 36 analysts: 8 strong buy, 14 buy, 13 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$163.43 mean target
+9.2% upside
Buy (2.08)
$145.00 Low
$186.00 High
| Metric | Value |
|---|---|
| Current Price | $149.61 |
| Target Low | $145.00 |
| Target Mean | $163.43 |
| Target Median | $164.00 |
| Target High | $186.00 |
| # Analysts | 23 |
| Recommendation | Buy (2.08) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.42 | $1.37 | $1.46 | -4.0% | -0.2% | 0↑ 15↓ | $21.5B | 2.7% | 19 |
| Next Q 2026-09-30 |
$1.97 | $1.93 | $2.07 | -0.8% | +0.1% | 0↑ 12↓ | $23.0B | 2.8% | 14 |
| Current FY 2026-06-30 |
$6.90 | $6.83 | $7.02 | 1.0% | -0.1% | 0↑ 19↓ | $87.1B | 3.4% | 24 |
| Next FY 2027-06-30 |
$7.09 | $6.96 | $7.34 | 2.8% | -0.1% | 0↑ 19↓ | $89.6B | 2.9% | 24 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.421 | |
| 7d ago | $1.423 | -0.002 |
| 30d ago | $1.425 | -0.003 |
| 60d ago | $1.520 | -0.099 |
| 90d ago | $1.529 | -0.108 |
11 analyst firms have rated this stock: 2 upgrades, 1 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 11, 2026 | Bernstein | INITIATE | — | Market Perform |
| Apr 27, 2026 | UBS | MAINTAIN | Buy | Buy |
| Apr 27, 2026 | TD Cowen | MAINTAIN | Hold | Hold |
| Apr 27, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 27, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Apr 17, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 10, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| Apr 8, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 8, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Apr 7, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | Deutsche Bank | MAINTAIN | Hold | Hold |
| Jan 27, 2026 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jan 23, 2026 | UBS | MAINTAIN | Buy | Buy |
| Jan 23, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Jan 23, 2026 | JP Morgan | UPGRADE | Neutral | Overweight |
| Jan 14, 2026 | UBS | MAINTAIN | Buy | Buy |
| Jan 8, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Jan 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Dec 18, 2025 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Dec 17, 2025 | Jefferies | UPGRADE | Hold | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 14 | 13 | 1 | 0 | 61% | |
| May 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Apr 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Mar 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Feb 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Jan 1, 2026 | 8 | 15 | 12 | 0 | 0 | 66% | |
| Dec 1, 2025 | 7 | 15 | 13 | 0 | 0 | 63% | |
| Nov 1, 2025 | 7 | 15 | 13 | 0 | 0 | 63% |
Strong BuyBuyHoldSellStrong Sell
5 members of Congress traded this stock: 5 buys, 3 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | May 8, 2026 (12d) |
| Apr 27, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | May 8, 2026 (12d) |
| Feb 26, 2026 | John Boozman | R | SENATE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Mar 6, 2026 (9d) |
| Feb 26, 2026 | David Taylor | R | HOUSE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Mar 9, 2026 (12d) |
| Feb 17, 2026 | Lloyd Doggett | D | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Mar 6, 2026 (18d) |
| Feb 9, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Feb 23, 2026 (15d) |
| Feb 2, 2026 | Julia Letlow | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Mar 13, 2026 (40d) |
| Jan 30, 2026 | Gilbert Cisneros | D | HOUSE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Feb 16, 2026 (18d) |
33°
Cool
Bearish
Neutral
Bullish
11 mentions
2 bullish
7 bearish
7 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 14, 2026 | 2 | 33° Cool | 0 | 2 | 2 |
| May 14, 2026 | 2 | 33° Cool | 0 | 2 | 2 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 18, 2026 | 3 | 36° Cool | 0 | 2 | 3 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jan 29, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Jul 27, 2026
earnings_calendar
PG Q4 2026 Earnings After Market Close — 2026-07-27
EPS est: $1.58 | Rev est: $22.2B
Jun 10, 2026
short_volume
Short Volume: PG — 57.6% short (1.5M / 2.6M)
Short: 1,487,208 | Exempt: 39,176 | TRF Vol: 2,582,329 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
Enforcement
The Scotts Co. LLC v. The Procter & Gamble Co.
Court ruling from Court of Appeals for the Sixth Circuit. Docket: 25-3555
Jun 1, 2026
Clinical Trial
Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
Phase Phase 3 — TERMINATED
May 27, 2026
short_volume
Short Volume: PG — 58.9% short (2.1M / 3.6M)
Short: 2,105,903 | Exempt: 32,359 | TRF Vol: 3,572,379 | Short Ratio: 58.9% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: PG — 56.4% short (1.2M / 2.1M)
Short: 1,189,869 | Exempt: 3,335 | TRF Vol: 2,108,534 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: PG — 6.9M shares, 138,496 trades
Week starting 2026-05-18. Total ATS volume: 6,906,325 shares across 138,496 trades.
May 15, 2026
short_volume
Short Volume: PG — 62.0% short (1.6M / 2.6M)
Short: 1,637,989 | Exempt: 99,962 | TRF Vol: 2,640,360 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: PG — 7.7M shares, 151,396 trades
Week starting 2026-05-11. Total ATS volume: 7,683,161 shares across 151,396 trades.
May 8, 2026
short_volume
Short Volume: PG — 58.8% short (1.1M / 1.9M)
Short: 1,091,060 | Exempt: 4,260 | TRF Vol: 1,854,738 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: PG — 59.9% short (1.3M / 2.2M)
Short: 1,318,804 | Exempt: 4,077 | TRF Vol: 2,201,752 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: PG — 59.8% short (1.8M / 3.0M)
Short: 1,807,127 | Exempt: 6,636 | TRF Vol: 3,019,886 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
May 4, 2026
Clinical Trial
Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.
Phase Phase 2 — COMPLETED
May 4, 2026
dark_pool
Dark Pool: PG — 7.7M shares, 147,275 trades
Week starting 2026-05-04. Total ATS volume: 7,747,725 shares across 147,275 trades.
Apr 28, 2026
short_volume
Short Volume: PG — 55.1% short (1.5M / 2.7M)
Short: 1,495,557 | Exempt: 24,102 | TRF Vol: 2,713,395 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
short_volume
Short Volume: PG — 61.0% short (2.0M / 3.3M)
Short: 2,042,042 | Exempt: 4,112 | TRF Vol: 3,345,034 | Short Ratio: 61.0% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: PG — 9.0M shares, 168,614 trades
Week starting 2026-04-27. Total ATS volume: 8,973,566 shares across 168,614 trades.
Apr 24, 2026
earnings_calendar
PG Q3 2026 Earnings Before Market Open — 2026-04-24